Cargando…

Serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study

BACKGROUND: Preliminary studies have suggested that the renin-angiotensin system is activated in critical illness and associated with mortality and kidney outcomes. We sought to assess in a larger, multicenter study the relationship between serum renin and Major Adverse Kidney Events (MAKE) in inten...

Descripción completa

Detalles Bibliográficos
Autores principales: Flannery, Alexander H., Ortiz-Soriano, Victor, Li, Xilong, Gianella, Fabiola G., Toto, Robert D., Moe, Orson W., Devarajan, Prasad, Goldstein, Stuart L., Neyra, Javier A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364694/
https://www.ncbi.nlm.nih.gov/pubmed/34391450
http://dx.doi.org/10.1186/s13054-021-03725-z
_version_ 1783738567705493504
author Flannery, Alexander H.
Ortiz-Soriano, Victor
Li, Xilong
Gianella, Fabiola G.
Toto, Robert D.
Moe, Orson W.
Devarajan, Prasad
Goldstein, Stuart L.
Neyra, Javier A.
author_facet Flannery, Alexander H.
Ortiz-Soriano, Victor
Li, Xilong
Gianella, Fabiola G.
Toto, Robert D.
Moe, Orson W.
Devarajan, Prasad
Goldstein, Stuart L.
Neyra, Javier A.
author_sort Flannery, Alexander H.
collection PubMed
description BACKGROUND: Preliminary studies have suggested that the renin-angiotensin system is activated in critical illness and associated with mortality and kidney outcomes. We sought to assess in a larger, multicenter study the relationship between serum renin and Major Adverse Kidney Events (MAKE) in intensive care unit (ICU) patients. METHODS: Prospective, multicenter study at two institutions of patients with and without acute kidney injury (AKI). Blood samples were collected for renin measurement a median of 2 days into the index ICU admission and 5–7 days later. The primary outcome was MAKE at hospital discharge, a composite of mortality, kidney replacement therapy, or reduced estimated glomerular filtration rate to ≤ 75% of baseline. RESULTS: Patients in the highest renin tertile were more severely ill overall, including more AKI, vasopressor-dependence, and severity of illness. MAKE were significantly greater in the highest renin tertile compared to the first and second tertiles. In multivariable logistic regression, this initial measurement of renin remained significantly associated with both MAKE as well as the individual component of mortality. The association of renin with MAKE in survivors was not statistically significant. Renin measurements at the second time point were also higher in patients with MAKE. The trajectory of the renin measurements between time 1 and 2 was distinct when comparing death versus survival, but not when comparing MAKE versus those without. CONCLUSIONS: In a broad cohort of critically ill patients, serum renin measured early in the ICU admission is associated with MAKE at discharge, particularly mortality. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-021-03725-z.
format Online
Article
Text
id pubmed-8364694
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83646942021-08-17 Serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study Flannery, Alexander H. Ortiz-Soriano, Victor Li, Xilong Gianella, Fabiola G. Toto, Robert D. Moe, Orson W. Devarajan, Prasad Goldstein, Stuart L. Neyra, Javier A. Crit Care Research BACKGROUND: Preliminary studies have suggested that the renin-angiotensin system is activated in critical illness and associated with mortality and kidney outcomes. We sought to assess in a larger, multicenter study the relationship between serum renin and Major Adverse Kidney Events (MAKE) in intensive care unit (ICU) patients. METHODS: Prospective, multicenter study at two institutions of patients with and without acute kidney injury (AKI). Blood samples were collected for renin measurement a median of 2 days into the index ICU admission and 5–7 days later. The primary outcome was MAKE at hospital discharge, a composite of mortality, kidney replacement therapy, or reduced estimated glomerular filtration rate to ≤ 75% of baseline. RESULTS: Patients in the highest renin tertile were more severely ill overall, including more AKI, vasopressor-dependence, and severity of illness. MAKE were significantly greater in the highest renin tertile compared to the first and second tertiles. In multivariable logistic regression, this initial measurement of renin remained significantly associated with both MAKE as well as the individual component of mortality. The association of renin with MAKE in survivors was not statistically significant. Renin measurements at the second time point were also higher in patients with MAKE. The trajectory of the renin measurements between time 1 and 2 was distinct when comparing death versus survival, but not when comparing MAKE versus those without. CONCLUSIONS: In a broad cohort of critically ill patients, serum renin measured early in the ICU admission is associated with MAKE at discharge, particularly mortality. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-021-03725-z. BioMed Central 2021-08-14 /pmc/articles/PMC8364694/ /pubmed/34391450 http://dx.doi.org/10.1186/s13054-021-03725-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Flannery, Alexander H.
Ortiz-Soriano, Victor
Li, Xilong
Gianella, Fabiola G.
Toto, Robert D.
Moe, Orson W.
Devarajan, Prasad
Goldstein, Stuart L.
Neyra, Javier A.
Serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study
title Serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study
title_full Serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study
title_fullStr Serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study
title_full_unstemmed Serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study
title_short Serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study
title_sort serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364694/
https://www.ncbi.nlm.nih.gov/pubmed/34391450
http://dx.doi.org/10.1186/s13054-021-03725-z
work_keys_str_mv AT flanneryalexanderh serumreninandmajoradversekidneyeventsincriticallyillpatientsamulticenterprospectivestudy
AT ortizsorianovictor serumreninandmajoradversekidneyeventsincriticallyillpatientsamulticenterprospectivestudy
AT lixilong serumreninandmajoradversekidneyeventsincriticallyillpatientsamulticenterprospectivestudy
AT gianellafabiolag serumreninandmajoradversekidneyeventsincriticallyillpatientsamulticenterprospectivestudy
AT totorobertd serumreninandmajoradversekidneyeventsincriticallyillpatientsamulticenterprospectivestudy
AT moeorsonw serumreninandmajoradversekidneyeventsincriticallyillpatientsamulticenterprospectivestudy
AT devarajanprasad serumreninandmajoradversekidneyeventsincriticallyillpatientsamulticenterprospectivestudy
AT goldsteinstuartl serumreninandmajoradversekidneyeventsincriticallyillpatientsamulticenterprospectivestudy
AT neyrajaviera serumreninandmajoradversekidneyeventsincriticallyillpatientsamulticenterprospectivestudy